Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Show More...

  • Website https://www.theratech.com
  • Sector Healthcare
  • Industry Drug Manufacturers-Specialty & Generic
  • Last Quote 3.63 CAD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-11 2011-11 2012-11 2013-11 2014-11 2015-11 2016-11 2017-11 2018-11 2019-11 TTM
    Earnings Per Share USD 0.15 -0.28 -0.23 -0.07 -0.15 0.010 0.010 -0.19 -0.06 -0.16 -0.2
    Dividends USD
    Payout Ratio % *
    Shares Mil 61.0 61.0 61.0 61.0 61.0 63.0 67.0 73.0 76.0 77.0 77.0
    Book Value Per Share * CAD 0.87 0.6 0.37 0.35 0.2 0.3 0.4 0.62 0.62 0.52 0.37
    Free Cash Flow Per Share * CAD 0.04 -0.45 -0.26 -0.17 -0.13 0.02 0.02 0.04 -0.03 -0.08
    Return on Assets % 12.88 -28.27 -31.97 -12.74 -35.46 3.56 0.79 -29.05 -5.31 -10.92 -13.92
    Financial Leverage (Average) 1.36 1.45 1.6 1.34 4.15 2.5 1.97 1.77 3.17 4.73 5.36
    Return on Equity % 18.97 -39.54 -48.38 -18.97 -75.68 10.76 1.74 -53.57 -13.21 -41.73 -57.72
    Return on Invested Capital % 15.73 -41.69 -50.75 -20.56 -70.27 23.12 7.45 -50.57 -3.65 -10.76 -14.61
    Interest Coverage 503.44 -26.99 -7.74 1.86 1.54 -12.46 -1.33 -1.5 -2.09
    Current Ratio 2.92 1.61 2.67 2.81 1.54 2.04 1.84 1.56 2.74 2.05 2.18
    Quick Ratio 2.45 0.47 0.51 0.33 0.49 1.18 0.93 1.15 2.22 1.37 1.41
    Debt/Equity 1.41 2.04 2.61